Concepedia

Caroline Phillips

CP

Statistics

Publications

8

Citations

202

H-Index

8

Active since

2011

Affiliations

Redx Pharma (United Kingdom)(Current)

Loughborough University

AstraZeneca (United Kingdom)

University of Manchester

AstraZeneca (Singapore)

Caroline Phillips is an author at Redx Pharma (United Kingdom) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2011–2022

8

Publications

8

Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist

David Nicholls, Katherine Wiley, Ian Dainty et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 90 citations

, , +17

The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand–dependent Cancer Models

Caroline Phillips, Inder Bhamra, Catherine Eagle et al. · Cancer Research Communications · 2022 · 33 citations · Full text

, , +16

Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists

Rupert P. Austin, Colin Bennion, Roger V. Bonnert et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 18 citations · Full text

, , +11

Lead optimisation of pyrazoles as novel FPR1 antagonists

Andrew Morley, Sarah King, Bryan Roberts et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 17 citations · Full text

, , +14

Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs

Sarah Brumskill, Lawrence N. Barrera, Peter Calcraft et al. · Journal of Physiology and Biochemistry · 2021 · 13 citations · Full text

, , +15

1–5 of 8